How Democratic Is Science Policy?

Who governs science and technology in a democracy? Can democracy and the world of science even be reconciled? In Governing Science and Technology in a Democracy (University of Tennessee Press, 1986), Malcolm L. Goggin, a political scientist and editor of the volume, presents viewpoints of a dozen professionals in science, law, philosophy and political science. The book is a collection of papers from a two-day conference in Houston in 1985. In this excerpt from the book, Goggin discusses four imp

Written byMalcolm Goggin
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

How one proceeds from this point depends on whether or not the argument that there is a governance problem at all is credible, and whether the crisis of governance is due to too much or too little democracy. I am convinced that both science and society would be better off if the United States were to move in the direction of more, rather than less, public governance of science and technology. The question is: How can science and technology be governed more democratically?

One answer is to remove some of the impediments to public participation in science and technology policy-making. There are at least four such impediments: an apathetic, scientifically illiterate citizenry, experts who believe in the republic of science, corporate capital that is shortsighted, and a university system that is losing its autonomy.

First, lay members of the public have little influence over policy for science and technology because ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies